Coagulase-negative Staphylococcus bacteraemia accounts for one third of Staphylococcus bacteraemia in a French university hospital

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 2, 2012, Pages 79-85

  N'Guyen, Yohan ^a   Baumard, Sonia ^a   Vernet Garnier, Véronique ^b   Batalla, Anne Sophie ^a   De Champs, Christophe ^b   Jaussaud, Roland ^a   Strady, Christophe ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

Acute renal failure; Bacteraemia; Coagulase negative Staphylococcus; Epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEOPLASM; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCAL BACTEREMIA; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; YOUNG ADULT;

EID: 84856083857     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.617777     Document Type: Article

References (40)

1. Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K. Health care-associated invasive MRSA infections, 2005 - 2008. JAMA 2010;304:641-8.
2. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997 - 2007. JAMA 2009;301:727-36.
3. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary care centre. Clin Microbiol Infect 2006;12:345-52. (Pubitemid 43337524)
4. Libert M, Elkhoti M, Massaut J, Karmali R, Mascart G, Cherifi S. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect 2008;68:17-24.
5. Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012-21. (Pubitemid 40965071)
6. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46:232-42. (Pubitemid 351269162)
7. Haro JL, Lomas JM, Plata A, Ruiz J, Gá l vez J, de la Torre J. Left-sided native valve endocarditis by coagulase-negative staphylococci: an emerging disease. Enferm Infecc Microbiol Clin 2008;26:263-8. (Pubitemid 351716795)
8. Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM. Relationship between vancomyin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother 2008;52:3315-20.
9. Soriano A, Marco F, Martí nez JA, Pisos E, Almela M, Dimova VP. Infl uence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:193-200. (Pubitemid 351269157)
10. Jones RN. Microbiological features of vancomycin in the 21st century. Minimum inhibitory concentration creep, bactericidal/static activity and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis 2006;42:S13 - 24.
11. Chang WN, Lu CH, Huang CR, Chuang YC, Tsai NW, Chen SF. Epidemiology of adult staphylococcal meningitis in southern Taiwan: a clinical comparison of Staphylococcus aureus infection and coagulase-negative staphylococcal infection. Jpn J Infect Dis 2007;60: 262-6.
12. Laguna-Del Estal P, Castaneda-Pastor A, Gil-Navarro M, Garcia-Madero R, Lopez-Cano Gomez M, Agud-Fernandez M. Comparative study of meningitis due to Staphylococcus aureus and coagulase-negative staphylococci in adults. Rev Neurol 2009;48:2-6.
13. Danese MD, Griffi ths RI, Dylan M, Yu HT, Dubois R, Nissenson AR. Mortality differences among organisms causing septicemia in hemodialysis patients. Hemodial Int 2006; 10:56-62. (Pubitemid 43263292)
14. Topeli A, Unal S, Hayran M, Akalin HE. Septic shock as a predictor of mortality in bacteremia caused by coagulasenegative staphylococci. Eur J Clin Microbiol Infect Dis 1997; 16:411-6. (Pubitemid 27343333)
15. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MT, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53 - 9 (Pubitemid 36099097)
16. Lodise TP, McKinnon PS, Levine DP, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillinsusceptible Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:3731 - 3. (Pubitemid 47519366)
17. Fowler VG, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB. Clinical identifi ers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003;163:2066-72. (Pubitemid 37151249)
18. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality and clinical impact of methicillin resistance. Medicine (Baltimore) 2003;82:322-32. (Pubitemid 37229467)
19. Comite de L' a ntibiogramme de la Societe Francaise de Microbiologie. Recommandations 2010 (Edition de Janvier 2010) Copyright 2010 - Soci é t é Fran ç aise de Microbiologie Coordonnateur: Pr C.J. SOUSSY Centre Hospitalier Universitaire Henri Mondor 94010 Creteil Cedex http://www. sfm-microbiologie.org/Userfiles/file/CASFM/casfm-2010. pdf accessed 22/09/2011.
20. Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003;24: 890-6. (Pubitemid 38029555)
21. Levy M, Fink M, Marshall JC, Abraham E, Angus D, Cook D. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Defi nitions Conference. Intensive Care Med 2003;29:530-8. (Pubitemid 36523666)
22. Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O'Connel B. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention defi nition for community- acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005;26: 204-9. (Pubitemid 40445027)
23. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-72. (Pubitemid 32405897)
24. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T. Proposed modifi cations to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
25. Bourneton O, Mutel T, Heranney D, Hernandez C, Lavigne T, Waller J. Incidence of hospital-acquired and communityacquired bloodstream infections in the University of Strasbourg Hospital, France, between 2005 and 2007. Pathol Biol (Paris) 2010;58:29-34.
26. Skogberg K, Lyytikäinen O, Ruutu P, Ollgren J, Nuorti JP. Increase in bloodstream infections in Finland, 1995 - 2002. Epidemiol Infect 2008;136:108-14.
27. Lyytikä i nen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P. Nosocomial bloodstream infections in Finnish Hospitals during 1999 - 2000. Clin Infect Dis 2002;35: e14 - 9.
28. Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T. Trends among pathogens reported as causing bacteraemia in England, 2004 - 2008. Clin Microbiol Infect 2011;17:451-8.
29. Von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2002;2:677-85. (Pubitemid 35265063)
30. Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM. Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 2003;82:333-9. (Pubitemid 37229468)
31. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower res - piratory tract infections. Clin Pharmacokinet 2004;43: 925-42. (Pubitemid 39447034)
32. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections. Effi cacy and toxicity. Arch Intern Med 2006;166:2138-44. (Pubitemid 44631403)
33. L odise TP, Lomaestro BM, Graves J, Drusano GL. Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother 2008;52:1330-6. (Pubitemid 351521995)
34. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration - time profi le and nephrotoxicity among hospitalized patients. Clin Infect Dis 2009;49:507-14.
35. Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia. Chest 2006;130:947-55.
36. Wunderink R, Rello J, Cammarata SK, Croos-Dabrera R, Kollef MH. Linezolid vs vancomycin: analysis of two doubleblind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003;124: 1789-97. (Pubitemid 37433574)
37. Rehm SJ, Boucher H, Levine D, Campion M, Eisenstein BI, Vigliani GA. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. J Antimicrob Chemother 2008; 62:1413-21.
38. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health- System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325-7.
39. Thylefors JD, Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fi ction or reality? Infect Control Hosp Epidemiol 1998;19:581-9. (Pubitemid 128472684)
40. Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D. Nosocomial bacteremia: clinical signifi cance of a single blood culture positive for coagulase-negative staphylococci. Infect Control Hosp Epidemiol 2005;26:697-702 (Pubitemid 41169739)